Episode Details

In this educational video, Leah Fingerman, NP, an interstitial lung disease (ILD) specialist at Emory Pulmonary, explores the three key drivers of pulmonary fibrogenesis and the underlying mechanisms contributing to the development and progression of pulmonary fibrosis. She discusses how repetitive injury to the alveolar epithelium, abnormal fibroblast activation, and genetic predisposition contribute to progressive lung scarring, impaired oxygen exchange, and declining pulmonary function. Leah highlights common environmental risk factors, including cigarette smoking, occupational exposures, air pollution, chronic aspiration, and potential viral triggers, while explaining how persistent fibroblast activation and excessive collagen production create a self-perpetuating cycle of lung fibrosis. She also examines the role of genetic mutations, including MUC5B, TERT, TERC, and other telomere-related genes, in influencing disease susceptibility and progression. With a focus on short telomere syndrome, Leah discusses its association with accelerated forced vital capacity (FVC) decline, poorer clinical outcomes, increased risks associated with immunosuppressive therapy, and complications following lung transplantation. This discussion provides pulmonologists, nurse practitioners, physician assistants, and other healthcare professionals with valuable insights into the pathophysiology of pulmonary fibrosis, genetic risk factors, and the clinical implications of progressive fibrotic interstitial lung disease. Visit the PulmHub for more expert-led pulmonary education and resources designed to support clinical practice.

Send us Fan Mail

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA

Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com

Follow us on:

• Instagram @pulmapps 
• Twitter@pulmapp 
• Facebook @association of pulmonary advance practice providers.